Non-Hodgkin's Lymphoma Protocols in the Treatment of Patients with Burkitt's Lymphoma and Lymphoblastic Lymphoma: A Report on 58 Patients

References

• Hiddemann W., Longo D. L., Coiftier B., Fisher R. I., Cabanillas F., Cavalli F., Nadler L. M., de Vita V. T., Lister T. A., Armitage J. O. Lymphoma classification-the gap between biology and clinical management is closing. Blood 1996; 88: 4085–4089
   PubMed Web of Science ®Google Scholar
• Wright D. H. What is Burkitt's lymphoma?. Journal of Pathology 1997; 182: 125–127
   PubMed Web of Science ®Google Scholar
• Magrath I., Adde M., Shad A., Venzon D., Seibel N., Gotenberg J., Neely J., Amdt C., Nieder M., Jaffe E., Wit-Tes R. A., Horak I. D. Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. Journal of Clinical Oncology 1996; 14: 925–934
   PubMed Web of Science ®Google Scholar
• Soussain C., Patte C., Ostronoff M., Delmer A, Rigal-Huguet F., Cambier N., Leprise P. -Y., Francois S., Cony-Makhoul P., Harousseau J. L., Janvier M., Chauvenet L., Witz F., Pico J. Small noncleaved cell lymphoma and leukemia in adults. A retrospecive study of 65 adults treated with the LBM pedriatric protocols. Blood 1995; 85: 664–674
   PubMed Web of Science ®Google Scholar
• Nathwani B. N., Diamond L. W., Winberg C. D., Km H., Bearman R. B., Glick J. H., Jones S. E., Gams R. A., Nissen N. I., Rappaport H. Lymphoblastic lymphoma: a clinicopathologic study of 95 patients. Cancer 1981; 48: 2347–2357
   PubMed Web of Science ®Google Scholar
• Köppler H., Pflüger K. H., Eschenbach I., Pfab R., Birk-Mann J., Filler W., Holle R., Steinhauer U. E., Gropp C., et al. Randomised comparison of CHOEP versus alternating hCHOP/ IVEP for high-grade non-Hodgkin's lympho-mas: treatment results and prognostic factor analysis in a multicentre trial. Annals of Oncology 1994; 5: 49–55
   PubMedGoogle Scholar
• Kaiser U., Uebelacker I., Havemann K. High dose chemotherapy with autologous stem cell transplantation in high grade NHL: first analysis of a randomized multi-center study. Bone Marrow Transplanfation 1998; 21%(Suppl 1)177
   Google Scholar
• Hoelzer D., Ludwig W. D., Thiel E., Gassmann W., Loffler H., Fronatsch C., Rieder H., Heil G., Heinze B., Amold R., Hossfeld D., et al. Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood 1996; 87: 495–508
   PubMed Web of Science ®Google Scholar
• Shipp M. A., Hanington D. P., Anderson J. R., Armitage J. O., Bonadonna G., Brittinger G. A predictive model for aggressive non-Hodgkin's lymphoma. The New England Journal of Medicine 1993; 329: 987–994, The International Non-Hodgkin's Lymphoma Prognostic Factors Project
   PubMed Web of Science ®Google Scholar
• Colgan J. P., Andersen J., Habermann T. M., Earle J. D., O'Connell M. J., Neimann R. S., Mann R. B., Glick J. H. Long-term follow-up of a CHOP-based regimen with maintenance therapy and central nervous system prophylaxis in lymphoblastic non-Hodgkin's lymphoma. Leukemia and Lymphoma 1994; 15: 291–296
   PubMed Web of Science ®Google Scholar
• Morel P., Lepage E., Brice P., Dupriez B., D'Agay M. -F., Fenaux P., Gosselin B., Bauters F., Gisselbrecht C. Prognosis and treatment of lymphoblastic lymphoma in adults: a report on 80 patients. Journal of Clinical Oncology 1992; 10: 1078–1085
   PubMed Web of Science ®Google Scholar
• Bouabdallah R., Xem L., Bardou V. J., Stoppa A. M., Blaiser D., Sainty D., Maraninchi D., Gastaut J. -A. Role of induction chemotherapy and bone marrow transplantation in adult lymphoblastic lymphoma: a report on 62 patients from a single center. Annals of Oncology 1998; 9: 619–625
   PubMed Web of Science ®Google Scholar
• Zinzani P. L., Gherlinzoni F., Bendandi M., Salvucci M., Tura S. Adult Burkitt's lymphoma: clinical and prognostic evaluation of 20 patients. Leukemia and Lymphoma 1994; 14: 465470
   Web of Science ®Google Scholar
• Zinzani P. L., Bendandi M., Visani G., Gherlinzoni F., Frezza G., Merla E., Manfroi S., Gozzetti A., Tura S. Adult lymphoblastic lymphoma: clinical features and prognostic factors in 53 patients. Leukemia and Lymphoma 1996; 23: 577–582
   PubMed Web of Science ®Google Scholar
• Sweetenham J. W., Liberti G., Pearce G., Taghipour G., Santini G., Goldstone A. H. High-dose therapy and autologous bone marrow transplantation for adult patients with lymphoblastic lymphoma: results of the European Group for bone marrow transplantation. Journal of Clinical Oncology 1994; 12: 135821365
   Google Scholar
• Sweetenham J. W., Pearce R., Taghipour G., Blaise D., Gisselbrecht C., Goldstone H. Adult Burkitt's and Burkitt-like Non-Hodgkin's lymphoma-outcome for patients treated with high-dose therapy and autologous stem-cell transplantation in first remission or at relapse: results from the European Group for blood and marrow transplantation. Journul of Clinical Oncology 1996; 14: 2465–2472
   PubMed Web of Science ®Google Scholar
• Jost LM., Jacky E., Dommann-Scherer C., Homegger H. -P., Maurer R., Sauter C., Stahel R. A. Short-term weekly chemotherapy followed by high-dose therapy with autologous bone-marrow transplantation for lymphoblastic and Burkitt's lymphoma in adult patients. Annals of Oncology 1995; 6: 445451
   Google Scholar
• de Witte T., Awward B., Boezemann J., Schattenberg A., Muus P., Raemaekers J., Preijers E, Strijckmanns P., Haanen C. Role of allogeneic bone marrow transplantation in adolescent or adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma in first remission. Bone Marrow Transplanrarion 1994; 14: 767–774
   PubMed Web of Science ®Google Scholar